New Delhi metallo-β-lactamase 1.

[1]  N. Woodford,et al.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.

[2]  P. Hawkey,et al.  The changing epidemiology of resistance. , 2009, The Journal of antimicrobial chemotherapy.

[3]  Timothy R. Walsh,et al.  Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.

[4]  Ronald N. Jones,et al.  Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  T. Johnson,et al.  Plasmid Replicon Typing of Commensal and Pathogenic Escherichia coli Isolates , 2007, Applied and Environmental Microbiology.

[6]  K. Kusza,et al.  Antimicrobial susceptibility of metallo-beta-lactamase positive and negative Klebsiella pneumoniae strains isolated from intensive care unit patients. , 2010, Polish journal of microbiology.

[7]  P. Nordmann,et al.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. , 2009, The Lancet. Infectious diseases.

[8]  A. Antoniadou,et al.  In Vitro Activity of Tigecycline against Multiple-Drug-Resistant, Including Pan-Resistant, Gram-Negative and Gram-Positive Clinical Isolates from Greek Hospitals , 2006, Antimicrobial Agents and Chemotherapy.

[9]  K. Bush,et al.  Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.

[10]  A. Peleg,et al.  Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Y. Carmeli,et al.  Treatment with Fluoroquinolones or with β-Lactam-β-Lactamase Inhibitor Combinations Is a Risk Factor for Isolation of Extended-Spectrum-β-Lactamase-Producing Klebsiella Species in Hospitalized Patients , 2010, Antimicrobial Agents and Chemotherapy.

[12]  A. Armaganidis,et al.  Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. , 2007, The Journal of antimicrobial chemotherapy.

[13]  Y. Ishii,et al.  Nosocomial outbreak of genetically related IMP-1 beta-lactamase-producing Klebsiella pneumoniae in a general hospital in Japan. , 2007, International journal of antimicrobial agents.

[14]  John Quale,et al.  Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. , 2005, Archives of internal medicine.

[15]  Richard A. Moore,et al.  Nosocomial Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa with a New blaIMP Allele, blaIMP-7 , 2002, Antimicrobial Agents and Chemotherapy.

[16]  F. Kapadia,et al.  New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised. , 2010, The Journal of the Association of Physicians of India.